Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)

About the company

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

4

$NoneM

Total Revenue

4

Employees

$14.20M

Market Capitalization

-1.87

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 375797.27 82729.00 6.04 21.90 20.75
Merck & Co., Inc. MRK 200455.93 48081.00 7.53 19.78 21.10
Pfizer Inc. PFE 190327.35 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110955.81 31006.00 2.69 94.33 3.08
Repligen Corp. RGEN 6333.69 286.00 6.07 275.98 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 4127.20 137.00 3.22 -8.98 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3604.64 1.00 33.33 -5.51 None
Allakos, Inc. ALLK 3162.63 None 6.87 -33.81 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2741.31 2.00 32.33 -23.50 None
Turning Point Therapeutics, Inc. TPTX 2310.84 None 6.95 -19.33 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2160.84 None 9.55 -5.18 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
OPKO Health, Inc. OPK 2088.87 891.00 1.48 -7.15 -32.92
Springworks Therapeutics, Inc. SWTX 1779.34 None 5.78 -28.54 None
Principia Biopharma, Inc. PRNB 1623.44 30.00 5.78 -23.10 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1556.96 None 9.54 -16.90 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Kiniksa Pharmaceuticals Ltd. KNSA 1401.40 None 7.26 -11.58 None
Akcea Therapeutics, Inc. AKCA 1348.30 341.00 2.77 -47.93 -8.59
Tricida, Inc. TCDA 1312.71 None 6.75 -6.22 None
Odonate Therapeutics, Inc. ODT 1232.79 None 10.10 -10.96 None
Arcutis Biotherapeutics, Inc. ARQT 1181.41 None 5.04 -18.89 None
Athenex, Inc. ATNX 1074.06 123.00 6.59 -9.98 -87.86
Phibro Animal Health Corp. PAHC 1066.00 818.00 5.38 28.89 4.49
Akero Therapeutics, Inc. AKRO 967.73 None 8.08 -19.07 None
Oric Pharmaceuticals, Inc. ORIC 957.32 None -10.39 -31.66 None
Constellation Pharmaceuticals, Inc. CNST 906.56 None 3.77 -9.77 None
G1 Therapeutics, Inc. GTHX 902.50 1.00 3.91 -6.88 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Applied Therapeutics, Inc. APLT 795.30 None 5.13 -16.14 None
Gossamer Bio, Inc. GOSS 793.00 None 3.22 -3.99 None
Phathom Pharmaceuticals, Inc. PHAT 783.75 None 4.35 -2.88 None
Krystal Biotech, Inc. KRYS 773.16 None 4.51 -37.28 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 635.68 1679.00 4.38 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 627.25 19.00 58.13 -22.55 -151.34
Oyster Point Pharma, Inc. OYST 611.52 None 6.14 -10.63 None
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
SIGA Technologies, Inc. SIGA 492.00 19.00 5.50 -25.00 -94.00
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 469.71 None 4.54 -13.35 None
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
Crinetics Pharmaceuticals, Inc. CRNX 423.84 1.00 5.35 -7.27 -447.78
DURECT Corp. DRRX 418.50 28.00 32.14 -17.31 -82.94
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
Fulcrum Therapeutics, Inc. FULC 392.61 1.00 6.62 -5.69 None
Relmada Therapeutics, Inc. RLMD 387.54 0.00 5.78 -32.38 -877.66
Kala Pharmaceuticals, Inc. KALA 383.40 6.00 4.19 -4.18 None
TCR2 Therapeutics, Inc. TCRR 381.12 None 2.61 -37.81 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 328.95 None 7.78 -5.04 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 307.89 4.00 9.72 -3.84 -523.27
89bio, Inc. ETNB 297.09 None 3.67 -4.60 None
HOOKIPA Pharma, Inc. HOOK 291.72 13.00 2.64 -6.45 -333.02
IDEAYA Biosciences, Inc. IDYA 284.20 None 4.32 -6.52 None
AMAG Pharmaceuticals, Inc. AMAG 280.33 321.00 1.07 -0.76 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 254.00 None 4.64 -8.33 None
Spero Therapeutics, Inc. SPRO 251.75 12.00 3.31 -3.10 -656.72
Gritstone Oncology, Inc. GRTS 235.80 4.00 2.11 -2.26 None
Kaleido Biosciences, Inc. KLDO 228.00 None 8.09 -3.11 None
KalVista Pharmaceuticals, Inc. KALV 218.16 12.00 2.41 -6.73 -263.38
Veru, Inc. VERU 218.08 39.00 7.29 -22.37 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Liquidia Technologies, Inc. LQDA 182.16 8.00 10.75 -3.70 -602.17
Galera Therapeutics, Inc. GRTX 180.50 None 3.37 -2.75 None
Sutro Biopharma, Inc. STRO 176.64 41.00 3.35 -2.90 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 168.00 532.00 30.88 -11.54 26.69
Evolus, Inc. EOLS 162.00 45.00 2.90 -1.60 -217.51
Evelo Biosciences, Inc. EVLO 159.36 None 4.08 -1.82 None
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
scPharmaceuticals, Inc. SCPH 140.50 119.00 3.59 -4.48 -27.05
Lyra Therapeutics, Inc. LYRA 135.12 1.00 -1.15 -8.10 -491.16
Harrow Health, Inc. HROW 134.68 51.00 8.63 -5.45 -47.54
PhaseBio Pharmaceuticals, Inc. PHAS 133.40 2.00 2.47 -2.79 None
Aquestive Therapeutics, Inc. AQST 132.72 49.00 -7.65 -1.89 -139.64
Trevi Therapeutics, Inc. TRVI 125.82 None 2.67 -4.29 None
Mustang Bio, Inc. MBIO 125.80 None 2.94 -2.56 None
NeuBase Therapeutics, Inc. NBSE 122.92 None 51.65 -2.75 None
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
TFF Pharmaceuticals, Inc. TFFP 109.44 None 4.24 -2.82 None
Eton Pharmaceuticals, Inc. ETON 103.14 1.00 11.24 -5.16 None
Milestone Pharmaceuticals, Inc. MIST 94.25 None 0.93 -1.51 None
Clearside Biomedical, Inc. CLSD 82.00 6.00 10.53 -4.65 -293.61
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Corvus Pharmaceuticals, Inc. CRVS 78.01 None 1.25 -1.65 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 76.44 4.00 3.79 -0.59 None
Baudax Bio, Inc. BXRX 73.98 None -2.01 -1.05 None
Navidea Biopharmaceuticals, Inc. NAVB 69.19 1.00 -50.88 -6.26 -65.13
BiomX, Inc. PHGE 67.43 None 1.78 -1.57 None
Genprex, Inc. GNPX 59.66 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 59.40 192.00 1.03 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.31 1.00 -24.41 -2.03 -851.00
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Eyenovia, Inc. EYEN 45.28 None 4.56 -2.21 None
Moleculin Biotech, Inc. MBRX 44.35 None 3.86 -4.82 None
Edesa Biotech, Inc. EDSA 44.10 0.00 6.28 -0.46 -395.23
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.10 3.00 4.50 -1.39 -225.89
Mannatech, Inc. MTEX 33.83 156.00 1.43 7.62 3.45
CNS Pharmaceuticals, Inc. CNSP 33.44 None 5.81 -6.15 None
AgeX Therapeutics, Inc. AGE 32.90 2.00 -43.29 -2.71 -658.11
Acer Therapeutics, Inc. ACER 32.00 3.00 2.34 -1.23 -274.69
Aileron Therapeutics, Inc. ALRN 31.64 None 4.35 -1.19 None
Adamis Pharmaceuticals Corp. ADMP 31.30 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.52 None 2.79 -24.22 None
Citius Pharmaceuticals, Inc. CTXR 29.70 None 2.20 -1.72 None
Millendo Therapeutics, Inc. MLND 27.15 0.00 0.64 -0.58 None
Hoth Therapeutics, Inc. HOTH 25.30 None 7.03 -2.81 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.52 0.00 0.89 -0.90 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.96 1.00 8.31 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 14.20 None 3.46 -1.87 None
PDS Biotechnology Corp. PDSB 14.07 None 1.56 -0.55 None
Novan, Inc. NOVN 14.01 5.00 -3.22 -0.44 -602.34
Titan Pharmaceuticals, Inc. TTNP 11.80 4.00 4.92 -0.66 -437.91
Novus Therapeutics, Inc. NVUS 7.30 None 0.62 -0.35 None
Brickell Biotech, Inc. BBI 5.00 5.00 1.64 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Adial Pharmaceutical, Inc.: Adial Pharmaceuticals Announces Commencement of Landmark ONWARD Pivotal Phase 3 Trial in Poland

7d ago, source: Finanznachrichten

Polish clinical sites initiated less than two weeks after regulatory approval CHARLOTTESVILLE, VA / ACCESSWIRE / June 25, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial"), a clinical- ...

ADIL Adial Pharmaceuticals, Inc Common Stock

13d ago, source: Nasdaq

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Adial Pharmaceuticals Closes Previously Announced $5.2 Million Registered Direct Offering

17d ago, source: YAHOO!

CHARLOTTESVILLE, VA / ACCESSWIRE / June 15, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ("Adial" or the "Company"), a biopharmaceutical company focused on the development of treatments ...

ADial Pharmaceuticals Inc.

10d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Adial Pharmaceuticals Inc (NASDAQ:ADIL) Short Interest Up 110.3% in June

12d ago, source: modernreaders.com

Adial Pharmaceuticals Inc (NASDAQ:ADIL) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 8,200 shares, an increase of 110.3% from ...

Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market

23d ago, source: MarketWatch

The MarketWatch News Department was not involved in the creation of this content. June 09, 2020 (ACCESSWIRE via COMTEX) -- CHARLOTTESVILLE, VA / ACCESSWIRE / June 9, 2020 / Adial Pharmaceuticals ...

Adial Pharmaceuticals Announces Commencement of Landmark ONWARD(TM) Pivotal Phase 3 Trial in Poland

7d ago, source: Associated Press

Polish clinical sites initiated less than two weeks after regulatory approval CHARLOTTESVILLE, VA / ACCESSWIRE / June 25, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) (“Adial”), a ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.